Akorn Appoints Terry Rappuhn to Board of Directors
24 avr. 2015 16h10 HE
|
Akorn, Inc.
LAKE FOREST, Ill., April 24, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX) today announced the appointment of Terry Allison Rappuhn to its Board of Directors and the Board's Audit Committee,...
Akorn to Make Additional Financial Restatements
24 avr. 2015 16h05 HE
|
Akorn, Inc.
LAKE FOREST, Ill., April 24, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX) today announced that it will restate its previously issued financial statements for the annual period ending December...
Akorn Launches Phenylephrine HCl Ophthalmic Solution
20 mars 2015 07h00 HE
|
Akorn, Inc.
LAKE FOREST, Ill., March 20, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty pharmaceutical company, today announced that it has launched Phenylephrine HCl Ophthalmic Solution,...
Akorn Files Annual Report on Form 10-K for Year Ended December 31, 2014; Restates Second and Third Quarter 2014 Financial Statements
17 mars 2015 16h05 HE
|
Akorn, Inc.
LAKE FOREST, Ill., March 17, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX) (the Company), today announced that the Company will file its Annual Report on Form 10-K for the year ended December...
Akorn Provides Update on Recent Product Launches
11 mars 2015 07h00 HE
|
Akorn, Inc.
LAKE FOREST, Ill., March 11, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty pharmaceutical company, today announced several generic product launches that build on Akorn's...
Akorn Reaffirms 2015 Revenue and EPS Guidance
10 mars 2015 09h08 HE
|
Akorn, Inc.
LAKE FOREST, Ill., March 10, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX) reaffirms its 2015 EPS metrics issued on February 26, 2015 calling for revenue of between $960 million and $980 million...
Akorn Adopts Comprehensive Policy to Support the Use of Its Products to Promote Human Health
04 mars 2015 07h00 HE
|
Akorn, Inc.
- Akorn Will Not Ship Directly to Prisons -
- Programs to Be Put In Place to Limit Potential Product Diversion for Executions -
LAKE FOREST, Ill., March 4, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc....
Akorn Announces Filing Extension for Form 10-K
02 mars 2015 16h00 HE
|
Akorn, Inc.
LAKE FOREST, Ill., March 2, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), today announced that the Company filed a Form 12b-25, Notification of Late Filing with the U.S. Securities and Exchange...
Akorn to Present at the Barclays Global Healthcare Conference
27 févr. 2015 07h00 HE
|
Akorn, Inc.
LAKE FOREST, Ill., Feb. 27, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a specialty generic pharmaceutical company, announced today that Tim Dick, Chief Financial Officer, will provide an...
CORRECTING and REPLACING -- Akorn Reports Preliminary Fourth Quarter and Full Year 2014 Results
26 févr. 2015 09h31 HE
|
Akorn, Inc.
- Fourth Quarter GAAP EPS of $0.29; Non-GAAP Adjusted EPS of $0.50 -
- 2015 Revenue Guidance of Between $960 million and $980 million -
- 2015 Non-GAAP Adjusted EPS Guidance of $1.88 - $1.98 -...